Hypoglycemics - Sulfonylureas and Related Non-Sulfonylureas

Hypoglycemics – sulfonylureas and related non-sulfonylureas (commonly termed meglitinides or glinides) is a therapeutic category of oral antidiabetic secretagogues

Hypoglycemics – sulfonylureas and related non-sulfonylureas (commonly termed meglitinides or glinides) is a therapeutic category of oral antidiabetic secretagogues

These agents function primarily by binding to sulfonylurea receptor subunits on ATP-sensitive potassium channels in pancreatic beta cells, triggering channel closure, membrane depolarization, and subsequent calcium-dependent insulin exocytosis

While sulfonylureas provide prolonged insulin release, the non-sulfonylurea glinides exhibit a more rapid onset and shorter duration of action to target postprandial glucose surges

While sulfonylureas provide prolonged insulin release, the non-sulfonylurea glinides exhibit a more rapid onset and shorter duration of action to target postprandial glucose surges

Clinically, these agents are indicated as adjuncts to diet and exercise to improve glycemic control exclusively in adults with type 2 diabetes mellitus